Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule

Nature Immunology

Volumn 1, Issue 6, 2000, Pages 489-495

  Holler, Nils ^a   Zaru, Rossana ^a   Micheau, Olivier ^a   Thome, Margot ^a   Attinger, Antoine ^a   Valitutti, Salvatore ^a   Bodmer, Jean Luc ^a   Schneider, Pascal ^a   Seed, Brian ^b   Tschopp, Jürg ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; CASP8 PROTEIN, HUMAN; CASP8 PROTEIN, MOUSE; CASP9 PROTEIN, HUMAN; CASP9 PROTEIN, MOUSE; CASPASE; CASPASE 8; CASPASE 9; FADD PROTEIN, HUMAN; FADD PROTEIN, MOUSE; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; FASL PROTEIN, MOUSE; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK1 PROTEIN, HUMAN; RIPK1 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TNFSF10 PROTEIN, HUMAN; TNFSF10 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CELL DEATH; CYTOLOGY; HUMAN; IN VITRO STUDY; LEUKEMIA CELL LINE; METABOLISM; MOUSE; NECROSIS; PHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; CASPASE 8; CASPASE 9; CASPASES; CELL DEATH; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; NECROSIS; PROTEINS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 5944233768     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/82732     Document Type: Article

References (37)

1. Kerr, J., Wyllie, A. H. & Currie, A. R. Apoptosis a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 68, 239-257 (1972).
2. Fiers, W., Beyaert, R., Declercq, W. & Vandenabeele, P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18, 7719-7730 (1999).
3. Scaffidi, C., Kirchhoff, S., Krammer, P. H. & Peter, M. E. Apoptosis signaling in lymphocytes. Curr. Opin. Immunol. 11, 277-285 (1999).
4. Vercammen, D. et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med 188, 919-930 (1998).
5. Kawahara, A., Ohsawa, Y., Matsumura, H., Uchiyama, Y. & Nagata, S. Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 143, 1353-1360 (1998).
6. Schneider, P. et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with down regulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187, 1205-1213 (1998).
7. Klas, C., Debatin, K. M., Jonker, R. R. & Krammer, P. H. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5, 625-630 (1993).
8. Irmler, M. et al. Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195 (1997).
9. Smith, K. G., Strasser, A. & Vaux, D. L. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15, 5167-5176 (1996).
10. Juo, P., Kuo, C. J., Yuan, J. & Blenis, J. Essential requirement for caspase-8/FLICE in the initiation of the Fas- induced apoptotic cascade. Curr. Biol. 8, 1001-1008 (1998).
11. Juo, P. et al. FADD is required for multiple signaling events downstream of the receptor Fas. Cell Growth Differ. 10, 797-804 (1999).
12. Kataoka, T. et al. The caspase-8 inhibitor FLIP promotes activation of NF-κB and erk signaling pathways. Curr. Biol. 10, 640-648 (2000).
13. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E. & Seed, B. RIP - a novel protein containing a death domain that interacts with Fas/Apo-1 (CD95) in yeast and causes cell death. Cell 81, 513-523 (1995).
14. Ting, A. T., Pimentel-Muinos, F. X. & Seed, B. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J. 15, 6189-6196 (1996).
15. Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297-303 (1998).
16. Grimm, S., Stanger, B. Z. & Leder, P. RIP and FADD: two "death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proc. Natl. Acad. Sci. USA 93, 10923-10927 (1996).
17. Hsu, H., Huang, J., Shu, H. B., Baichwal, V. & Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396 (1996).
18. Lewis, J. et al. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation. J. Biol. Chem. 275, 10519-10526 (2000).
19. Zhang, S. Q., Kovalenko, A., Cantarella, G. & Wallach, D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation. Immunity 12, 301-311 (2000).
20. Kroemer, G. & Reed, J. C. Mitochondrial control of cell death. Nature Med. 6, 513-519 (2000).
21. Li, H., Zhu, H., Xu, C. J. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501 (1998).
22. Luo, X., Budihardjo, I., Zou, H., Slaughter, C. & Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490 (1998).
23. Vercammen, D. et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477-1485 (1998).
24. Pimentel-Muinos, F. X. & Seed, B. Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 11, 783-793 (1999).
25. Bodmer, J. L. et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nature Cell Biol. 2, 241-243 (2000).
26. Kischkel, F. C. et al. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12, 611-620 (2000).
27. Sprick, M. R. et al. FADD/MORTI and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12, 599-609 (2000).
28. Khwaja, A. & Tatton, L. Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J. Biol. Chem. 274, 36817-36823 (1999).
29. Boone, E. et al. Structure/Function Analysis of p55 Tumor Necrosis Factor Receptor and Fas-Associated Death Domain: Effect on Necrosis in L929sA Cells. J. Biol. Chem. (in the press2000).
30. Luschen, S., Ussat, S., Scherer, G., Kabelitz, D. & Adam-Klages, S. Sensitization to death receptor cytotoxicity by inhibition of fas- associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. J. Biol. Chem. 275, 24670-24678 (2000).
31. Walsh, C. M. et al. A role for FADD in T cell activation and development. Immunity 8, 439-449 (1998).
32. Watanabe, F. R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. & Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317 (1992).
33. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med. 5, 1249-1255 (1999).
34. Baker, B., Zambryski, P., Staskawicz, B. & Dinesh-Kumar, S. P. Signaling in plant-microbe interactions. Science 276, 726-733 (1997).
35. Berndt, C., Mopps, B., Angermuller, S., Gierschik, P. & Krammer, P. H. CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells. Proc. Natl Acad. Sci. USA 95, 12556-12561 (1998).
36. Drenou, B. et al. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J. Immunol. 163, 4115-4124 (1999).
37. Kitanaka, C. & Kuchino, Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 6, 508-515 (1999).